Skip to main content

Table 3 MiR-182-5p expression in LUAD from miRNA-seq data

From: MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Characteristics

n

Relevant expression of miR-182-5p (log2x)

Mean ± SD

t/F-value

P-value

Tissue

LUAD

448

14.273 ± 0.947

17.368

< 0.001*

Noncancerous

45

11.644 ± 1.160

Gender

Male

209

14.259 ± 0.902

−0.306

0.760

Female

239

14.286 ± 0.987

Age(years)

≤50

33

14.295 ± 1.205

0.175

0.862

> 50

396

14.257 ± 0.932

T

T1 + T2

388

14.294 ± 0.954

0.679

0.497

T3 + T4

57

14.203 ± 0.871

Nodes

No

293

14.252 ± 0.966

−1.025

0.306

Yes

146

14.349 ± 0.892

Metastasis

No

285

14.326 ± 0.898

−0.366

0.715

Yes

19

14.404 ± 1.027

Pathologic stage

I-II

351

14.249 ± 0.958

−0.810

0.419

III-IV

92

14.340 ± 0.918

Anatomic neoplasm subdivision

L-Lower

70

14.229 ± 0.825

0.512a

0.727

L-Upper

108

14.206 ± 0.998

R-Lower

85

14.214 ± 0.940

R-Middle

18

14.281 ± 0.789

R-Uppr

155

14.351 ± 0.986

Tumor location

Peripheral

113

14.309 ± 0.940

−0.743

0.459

Central

54

14.429 ± 1.051

  1. LUAD: lung adenocarcinoma; SD: standard deviation
  2. a One-way analysis of variance (ANOVA) was performed
  3. * The results were statistically significant (P < 0.05)